Fidelta combines expertise in the areas of chemistry, pharmacology, ADME, pharmacokinetics and toxicology offering integrated discovery services to the biotech, pharmaceutical, agrochemical, food, cosmetic and chemical industries. At Fidelta, integrated drug discovery is driven by our determination to deliver EFFICACIOUS, SAFE and DIFFERENTIATED PRECLINICAL CANDIDATES. Our integrated drug discovery platform is built upon:
• Our extensive experience in drug discovery, from target validation to early preclinical development
• A full range of in house drug discovery capabilities including chemistry, pharmacology, ADME, pharmacokinetics and toxicology
• Our therapeutic area expertise, targeting inflammation (and linked conditions in the fields of infection, oncology, metabolic disease) and antibacterials
• A strong emphasis on translational science, focusing on patients and disease-relevant test models/systems
• Our multidisciplinary team of high-performing bench scientists. Of particular note are the extensive AAALAC accredited in vivo capabilities giving the possibility to take projects all the way to the clinic. Specialties
Preclinical drug discovery services, Integrated drug discovery, Efficacy & Safety, AAALAC, Macrocyclic chemistry
